These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 35419377)
21. Abnormal mRNA Splicing Effect of Zhang Y; Wang X; Zhou J; Ding J; Wang F Kidney Int Rep; 2023 Jul; 8(7):1399-1406. PubMed ID: 37441478 [TBL] [Abstract][Full Text] [Related]
22. Novel mutations of COL4A3, COL4A4, and COL4A5 genes in Chinese patients with Alport Syndrome using next generation sequence technique. Zhao X; Chen C; Wei Y; Zhao G; Liu L; Wang C; Zhang J; Kong X Mol Genet Genomic Med; 2019 Jun; 7(6):e653. PubMed ID: 30968591 [TBL] [Abstract][Full Text] [Related]
23. Collagen type IV-related nephropathies in Portugal: pathogenic COL4A3 and COL4A4 mutations and clinical characterization of 25 families. Nabais Sá MJ; Storey H; Flinter F; Nagel M; Sampaio S; Castro R; Araújo JA; Gaspar MA; Soares C; Oliveira A; Henriques AC; da Costa AG; Abreu CP; Ponce P; Alves R; Pinho L; Silva SE; de Moura CP; Mendonça L; Carvalho F; Pestana M; Alves S; Carvalho F; Oliveira JP Clin Genet; 2015 Nov; 88(5):456-61. PubMed ID: 25307543 [TBL] [Abstract][Full Text] [Related]
24. Guidelines for Genetic Testing and Management of Alport Syndrome. Savige J; Lipska-Zietkiewicz BS; Watson E; Hertz JM; Deltas C; Mari F; Hilbert P; Plevova P; Byers P; Cerkauskaite A; Gregory M; Cerkauskiene R; Ljubanovic DG; Becherucci F; Errichiello C; Massella L; Aiello V; Lennon R; Hopkinson L; Koziell A; Lungu A; Rothe HM; Hoefele J; Zacchia M; Martic TN; Gupta A; van Eerde A; Gear S; Landini S; Palazzo V; Al-Rabadi L; Claes K; Corveleyn A; Van Hoof E; van Geel M; Williams M; Ashton E; Belge H; Ars E; Bierzynska A; Gangemi C; Renieri A; Storey H; Flinter F Clin J Am Soc Nephrol; 2022 Jan; 17(1):143-154. PubMed ID: 34930753 [TBL] [Abstract][Full Text] [Related]
25. Increased prevalence of kidney cysts in individuals carrying heterozygous COL4A3 or COL4A4 pathogenic variants. Furlano M; Pilco-Teran M; Pybus M; Martínez V; Aza-Carmona M; Rius Peris A; Pérez-Gomez V; Berná G; Mazon J; Hernández J; Fayos de Arizón L; Viera E; Gich I; Pérez HV; Gomá-Garcés E; Albero Dolon JL; Ars E; Torra R Nephrol Dial Transplant; 2024 Aug; 39(9):1442-1448. PubMed ID: 38317457 [TBL] [Abstract][Full Text] [Related]
26. COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. Longo I; Porcedda P; Mari F; Giachino D; Meloni I; Deplano C; Brusco A; Bosio M; Massella L; Lavoratti G; Roccatello D; Frascá G; Mazzucco G; Muda AO; Conti M; Fasciolo F; Arrondel C; Heidet L; Renieri A; De Marchi M Kidney Int; 2002 Jun; 61(6):1947-56. PubMed ID: 12028435 [TBL] [Abstract][Full Text] [Related]
27. Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy. Weber S; Strasser K; Rath S; Kittke A; Beicht S; Alberer M; Lange-Sperandio B; Hoyer PF; Benz MR; Ponsel S; Weber LT; Klein HG; Hoefele J Pediatr Nephrol; 2016 Jun; 31(6):941-55. PubMed ID: 26809805 [TBL] [Abstract][Full Text] [Related]
28. Genetic and molecular dynamics analysis of two variants of the COL4A5 gene causing Alport syndrome. Liang L; Wu H; Cai Z; Zhao J BMC Med Genomics; 2023 Aug; 16(1):192. PubMed ID: 37596645 [TBL] [Abstract][Full Text] [Related]
29. Whole exome sequencing reveals novel COL4A3 and COL4A4 mutations and resolves diagnosis in Chinese families with kidney disease. Lin F; Bian F; Zou J; Wu X; Shan J; Lu W; Yao Y; Jiang G; Gale DP BMC Nephrol; 2014 Nov; 15():175. PubMed ID: 25381091 [TBL] [Abstract][Full Text] [Related]
35. Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort Study. Furlano M; Martínez V; Pybus M; Arce Y; Crespí J; Venegas MDP; Bullich G; Domingo A; Ayasreh N; Benito S; Lorente L; Ruíz P; Gonzalez VL; Arlandis R; Cabello E; Torres F; Guirado L; Ars E; Torra R Am J Kidney Dis; 2021 Oct; 78(4):560-570.e1. PubMed ID: 33838161 [TBL] [Abstract][Full Text] [Related]
36. Genetic Variants of the COL4A3 , COL4A4 , and COL4A5 Genes Contribute to Thinned Glomerular Basement Membrane Lesions in Sporadic IgA Nephropathy Patients. Yuan X; Su Q; Wang H; Shi S; Liu L; Lv J; Wang S; Zhu L; Zhang H J Am Soc Nephrol; 2023 Jan; 34(1):132-144. PubMed ID: 36130833 [TBL] [Abstract][Full Text] [Related]
37. Thin basement membrane nephropathy. Savige J; Rana K; Tonna S; Buzza M; Dagher H; Wang YY Kidney Int; 2003 Oct; 64(4):1169-78. PubMed ID: 12969134 [TBL] [Abstract][Full Text] [Related]
38. Is there a dominant-negative effect in individuals with heterozygous disease-causing variants in COL4A3/COL4A4? Riedhammer KM; Simmendinger H; Tasic V; Putnik J; Abazi-Emini N; Stajic N; Berutti R; Weidenbusch M; Patzer L; Lungu A; Milosevski-Lomic G; Günthner R; Braunisch MC; Ćomić J; Hoefele J Clin Genet; 2024 Apr; 105(4):406-414. PubMed ID: 38214412 [TBL] [Abstract][Full Text] [Related]
39. Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome. Liu JH; Wei XX; Li A; Cui YX; Xia XY; Qin WS; Zhang MC; Gao EZ; Sun J; Gao CL; Liu FX; Wu QY; Li WW; Asan ; Liu ZH; Li XJ PLoS One; 2017; 12(5):e0177685. PubMed ID: 28542346 [TBL] [Abstract][Full Text] [Related]